Cover Image
Market Research Report

Global Quetiapine Fumarate Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

Published by QYResearch Product code 675332
Published Content info 110 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Quetiapine Fumarate Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
Published: August 14, 2018 Content info: 110 Pages
Description

This study researches the market size of Quetiapine Fumarate, presents the global Quetiapine Fumarate sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

This report focuses on the key data information of Quetiapine Fumarate in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Quetiapine Fumarate for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

The Quetiapine Fumarate was developed by AstraZeneca from 1992 to 1996. It was first approved by the FDA in 1997.

The product is invented and first produced in the UK by AstraZeneca. AstraZeneca is also the leader of the Quetiapine Fumarate base drugs.

The Average gross of the industry is over 40%. However, since there are new companies coming into the area, the gross is declining in the last several years.

In 2018, the global Quetiapine Fumarate market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Quetiapine Fumarate.

This report includes the following manufacturers; we can also add the other companies as you want.

  • AstraZeneca
  • Intas
  • TAPI
  • Accord
  • Hexal
  • Dr.Reddy's
  • Lupin
  • Sun Pharmaceutical
  • Hunan Dongting Pharm
  • SuZhou NO.4 Phamaceutical Factory
  • Fuan Pharmaceutical
  • Zhejiang Supor Pharmaceuticals
  • Zhejiang Huahai Pharmaceutical

Market Segment by Product Type:

  • Immediate Release Tablets
  • Extended Release Tablets

Market Segment by Application:

  • Application 1
  • Application 2

Market size split by Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global Quetiapine Fumarate status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Quetiapine Fumarate manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Quetiapine Fumarate are as follows:

  • History Year: 2013-2018
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025
Table of Contents

Table of Contents

1. Report Overview

  • 1.1. Research Scope
  • 1.2. Major Manufacturers Covered in This Report
  • 1.3. Market Segment by Type
  • 1.4. Market Segment by Application
  • 1.5. Study Objectives
  • 1.6. Years Considered

2. Global Growth Trends

  • 2.1. Global Quetiapine Fumarate Market Size
    • 2.1.1. Global Quetiapine Fumarate Revenue 2013-2025
    • 2.1.2. Global Quetiapine Fumarate Sales 2013-2025
  • 2.2. Quetiapine Fumarate Growth Rate by Regions
    • 2.2.1. Global Quetiapine Fumarate Sales by Regions 2013-2018
    • 2.2.2. Global Quetiapine Fumarate Revenue by Regions 2013-2018
  • 2.3. Industry Trends
    • 2.3.1. Market Top Trends
    • 2.3.2. Market Drivers

3. Market Share by Manufacturers

  • 3.1. Quetiapine Fumarate Sales by Manufacturers
    • 3.1.1. Quetiapine Fumarate Sales by Manufacturers 2013-2018
    • 3.1.2. Quetiapine Fumarate Sales Market Share by Manufacturers 2013-2018
  • 3.2. Revenue by Manufacturers
    • 3.2.1. Quetiapine Fumarate Revenue by Manufacturers (2013-2018)
    • 3.2.2. Quetiapine Fumarate Revenue Share by Manufacturers (2013-2018)
    • 3.2.3. Global Quetiapine Fumarate Market Concentration Ratio (CR5 and HHI)
  • 3.3. Quetiapine Fumarate Price by Manufacturers
  • 3.4. Key Manufacturers Quetiapine Fumarate Plants/Factories Distribution and Area Served
  • 3.5. Date of Key Manufacturers Enter into Quetiapine Fumarate Market
  • 3.6. Key Manufacturers Quetiapine Fumarate Product Offered
  • 3.7. Mergers & Acquisitions, Expansion Plans

4. Market Size by Type

  • 4.2. Global Quetiapine Fumarate Sales Market Share by Type
  • 4.3. Global Quetiapine Fumarate Revenue Market Share by Type
  • 4.4. Quetiapine Fumarate Price by Type

5. Market Size by Application

  • 5.1. Overview
  • 5.2. Global Quetiapine Fumarate Sales by Application

6. North America

  • 6.1. North America Quetiapine Fumarate Breakdown Data by Company
  • 6.2. North America Quetiapine Fumarate Breakdown Data by Type
  • 6.3. North America Quetiapine Fumarate Breakdown Data by Application
  • 6.4. North America Quetiapine Fumarate Breakdown Data by Countries
    • 6.4.1. North America Quetiapine Fumarate Sales by Countries
    • 6.4.2. North America Quetiapine Fumarate Revenue by Countries
    • 6.4.3. United States
    • 6.4.4. Canada
    • 6.4.5. Mexico

7. Europe

  • 7.1. Europe Quetiapine Fumarate Breakdown Data by Company
  • 7.2. Europe Quetiapine Fumarate Breakdown Data by Type
  • 7.3. Europe Quetiapine Fumarate Breakdown Data by Application
  • 7.4. Europe Quetiapine Fumarate Breakdown Data by Countries
    • 7.4.1. Europe Quetiapine Fumarate Sales by Countries
    • 7.4.2. Europe Quetiapine Fumarate Revenue by Countries
    • 7.4.3. Germany
    • 7.4.4. France
    • 7.4.5. UK
    • 7.4.6. Italy
    • 7.4.7. Russia

8. Asia Pacific

  • 8.1. Asia Pacific Quetiapine Fumarate Breakdown Data by Company
  • 8.2. Asia Pacific Quetiapine Fumarate Breakdown Data by Type
  • 8.3. Asia Pacific Quetiapine Fumarate Breakdown Data by Application
  • 8.4. Asia Pacific Quetiapine Fumarate Breakdown Data by Countries
    • 8.4.1. Asia Pacific Quetiapine Fumarate Sales by Countries
    • 8.4.2. Asia Pacific Quetiapine Fumarate Revenue by Countries
    • 8.4.3. China
    • 8.4.4. Japan
    • 8.4.5. Korea
    • 8.4.6. India
    • 8.4.7. Australia
    • 8.4.8. Indonesia
    • 8.4.9. Malaysia
    • 8.4.10. Philippines
    • 8.4.11. Thailand
    • 8.4.12. Vietnam

9. Central & South America

  • 9.1. Central & South America Quetiapine Fumarate Breakdown Data by Company
  • 9.2. Central & South America Quetiapine Fumarate Breakdown Data by Type
  • 9.3. Central & South America Quetiapine Fumarate Breakdown Data by Application
  • 9.4. Central & South America Quetiapine Fumarate Breakdown Data by Countries
    • 9.4.1. Central & South America Quetiapine Fumarate Sales by Countries
    • 9.4.2. Central & South America Quetiapine Fumarate Revenue by Countries
    • 9.4.3. Brazil

10. Middle East and Africa

  • 10.1. Middle East and Africa Quetiapine Fumarate Breakdown Data by Type
  • 10.2. Middle East and Africa Quetiapine Fumarate Breakdown Data by Application
  • 10.3. Middle East and Africa Quetiapine Fumarate Breakdown Data by Countries
    • 10.3.1. Middle East and Africa Quetiapine Fumarate Sales by Countries
    • 10.3.2. Middle East and Africa Quetiapine Fumarate Revenue by Countries
    • 10.3.3. GCC Countries
    • 10.3.4. Egypt
    • 10.3.5. South Africa

11. Company Profiles

  • 11.1. AstraZeneca
    • 11.1.1. AstraZeneca Company Details
    • 11.1.2. Company Description and Business Overview
    • 11.1.3. Sales, Revenue and Market Share of Quetiapine Fumarate
    • 11.1.4. Quetiapine Fumarate Product Introduction
    • 11.1.5. AstraZeneca Recent Development
  • 11.2. Intas
    • 11.2.1. Intas Company Details
    • 11.2.2. Company Description and Business Overview
    • 11.2.3. Sales, Revenue and Market Share of Quetiapine Fumarate
    • 11.2.4. Quetiapine Fumarate Product Introduction
    • 11.2.5. Intas Recent Development
  • 11.3. TAPI
    • 11.3.1. TAPI Company Details
    • 11.3.2. Company Description and Business Overview
    • 11.3.3. Sales, Revenue and Market Share of Quetiapine Fumarate
    • 11.3.4. Quetiapine Fumarate Product Introduction
    • 11.3.5. TAPI Recent Development
  • 11.4. Accord
    • 11.4.1. Accord Company Details
    • 11.4.2. Company Description and Business Overview
    • 11.4.3. Sales, Revenue and Market Share of Quetiapine Fumarate
    • 11.4.4. Quetiapine Fumarate Product Introduction
    • 11.4.5. Accord Recent Development
  • 11.5. Hexal
    • 11.5.1. Hexal Company Details
    • 11.5.2. Company Description and Business Overview
    • 11.5.3. Sales, Revenue and Market Share of Quetiapine Fumarate
    • 11.5.4. Quetiapine Fumarate Product Introduction
    • 11.5.5. Hexal Recent Development
  • 11.6. Dr.Reddy's
    • 11.6.1. Dr.Reddy's Company Details
    • 11.6.2. Company Description and Business Overview
    • 11.6.3. Sales, Revenue and Market Share of Quetiapine Fumarate
    • 11.6.4. Quetiapine Fumarate Product Introduction
    • 11.6.5. Dr.Reddy's Recent Development
  • 11.7. Lupin
    • 11.7.1. Lupin Company Details
    • 11.7.2. Company Description and Business Overview
    • 11.7.3. Sales, Revenue and Market Share of Quetiapine Fumarate
    • 11.7.4. Quetiapine Fumarate Product Introduction
    • 11.7.5. Lupin Recent Development
  • 11.8. Sun Pharmaceutical
    • 11.8.1. Sun Pharmaceutical Company Details
    • 11.8.2. Company Description and Business Overview
    • 11.8.3. Sales, Revenue and Market Share of Quetiapine Fumarate
    • 11.8.4. Quetiapine Fumarate Product Introduction
    • 11.8.5. Sun Pharmaceutical Recent Development
  • 11.9. Hunan Dongting Pharm
    • 11.9.1. Hunan Dongting Pharm Company Details
    • 11.9.2. Company Description and Business Overview
    • 11.9.3. Sales, Revenue and Market Share of Quetiapine Fumarate
    • 11.9.4. Quetiapine Fumarate Product Introduction
    • 11.9.5. Hunan Dongting Pharm Recent Development
  • 11.10. SuZhou NO.4 Phamaceutical Factory
    • 11.10.1. SuZhou NO.4 Phamaceutical Factory Company Details
    • 11.10.2. Company Description and Business Overview
    • 11.10.3. Sales, Revenue and Market Share of Quetiapine Fumarate
    • 11.10.4. Quetiapine Fumarate Product Introduction
    • 11.10.5. SuZhou NO.4 Phamaceutical Factory Recent Development

12. Value Chain and Sales Channels Analysis

  • 12.1. Value Chain Analysis
  • 12.2. Sales Channels Analysis
    • 12.2.1. Quetiapine Fumarate Sales Channels
    • 12.2.2. Quetiapine Fumarate Distributors
  • 12.3. Quetiapine Fumarate Customers

13. Market Forecast

  • 13.1. Global Quetiapine Fumarate Sales and Revenue Forecast 2018-2025
  • 13.2. Global Quetiapine Fumarate Sales Forecast by Type
  • 13.3. Global Quetiapine Fumarate Sales Forecast by Application
  • 13.4. Quetiapine Fumarate Forecast by Regions
    • 13.4.1. Global Quetiapine Fumarate Sales Forecast by Regions 2018-2025
    • 13.4.2. Global Quetiapine Fumarate Revenue Forecast by Regions 2018-2025
  • 13.5. North America Market Forecast
    • 13.5.1. North America Quetiapine Fumarate Forecast by Countries 2018-2025
    • 13.5.2. United States
    • 13.5.3. Canada
    • 13.5.4. Mexico
  • 13.6. Europe Market Forecast
    • 13.6.1. Europe Quetiapine Fumarate Forecast by Countries 2018-2025
    • 13.6.2. Germany
    • 13.6.3. France
    • 13.6.4. UK
    • 13.6.5. Italy
    • 13.6.6. Russia
  • 13.7. Asia Pacific Market Forecast
    • 13.7.1. Asia Pacific Quetiapine Fumarate Sales Forecast by Countries 2018-2025
    • 13.7.2. China
    • 13.7.3. Japan
    • 13.7.4. Korea
    • 13.7.5. India
    • 13.7.6. Australia
    • 13.7.7. Indonesia
    • 13.7.8. Thailand
    • 13.7.9. Malaysia
    • 13.7.10. Philippines
    • 13.7.11. Vietnam
  • 13.8. Central & South America Market Forecast
    • 13.8.1. Central & South America Quetiapine Fumarate Sales Forecast by Countries 2018-2025
    • 13.8.2. Brazil
  • 13.9. Middle East and Africa Market Forecast
    • 13.9.1. Middle East and Africa Quetiapine Fumarate Sales Forecast by Countries 2018-2025
    • 13.9.2. GCC Countries
    • 13.9.3. Egypt
    • 13.9.4. South Africa

14. Research Findings and Conclusion

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
      • 15.1.1.1. Research Programs/Design
      • 15.1.1.2. Market Size Estimation
      • 15.1.1.3. Market Breakdown and Data Triangulation
    • 15.1.2. Data Source
      • 15.1.2.1. Secondary Sources
      • 13.1.2.2. Primary Sources
  • 15.2. Author Details
  • 15.3. Disclaimer

List of Tables and Figures

  • Figure Quetiapine Fumarate Product Picture
  • Table Quetiapine Fumarate Key Market Segments
  • Table Major Manufacturers Quetiapine Fumarate Covered in This Report
  • Table Global Quetiapine Fumarate Market Size Growth Rate by Type 2018-2025 (MT) & (Million US$)
  • Figure Global Quetiapine Fumarate Sales Market Shar by Type 2013-2025
  • Figure Immediate Release Tablets Figures
  • Figure Quetiapine Fumarate Report Years Considered
  • Figure Global Quetiapine Fumarate Market Size 2013-2025 (Million US$)
  • Figure Global Quetiapine Fumarate Sales 2013-2018 (MT)
  • Table Global Quetiapine Fumarate Market Size by Regions 2013-2018 (MT) & (Million US$)
  • Table Global Quetiapine Fumarate Sales by Regions 2013-2018 (MT)
  • Table Global Quetiapine Fumarate Sales Market Share by Regions 2013-2018
  • Figure Global Quetiapine Fumarate Sales Market Share by Regions 2013-2018
  • Figure Global Quetiapine Fumarate Sales Market Share by Regions in 2018
  • Table Global Quetiapine Fumarate Revenue by Regions 2013-2018 (Million US$)
  • Table Global Quetiapine Fumarate Revenue Market Share by Regions 2013-2018
  • Figure Global Quetiapine Fumarate Revenue Market Share by Regions 2013-2018
  • Figure Global Quetiapine Fumarate Revenue Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Global Quetiapine Fumarate Sales by Manufacturers (2013-2018) (MT)
  • Table Global Quetiapine Fumarate Sales Share by Manufacturers (2013-2018)
  • Figure Global Quetiapine Fumarate Sales Share by Manufacturers in 2018
  • Table Quetiapine Fumarate Revenue by Manufacturers (2013-2018) (Million USD)
  • Table Quetiapine Fumarate Revenue Share by Manufacturers (2013-2018)
  • Figure Quetiapine Fumarate Value Share by Manufacturers in 2018
  • Table Global Quetiapine Fumarate Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers Quetiapine Fumarate Price (2013-2018) (USD/Kg)
  • Table Key Manufacturers Quetiapine Fumarate Plants/Factories Distribution
  • Table Key Manufacturers Quetiapine Fumarate Area Served
  • Table Date of Key Manufacturers Enter into Quetiapine Fumarate Market
  • Table Key Manufacturers Quetiapine Fumarate Product Type
  • Table Global Quetiapine Fumarate Sales by Type (2013-2018) (MT)
  • Table Global Quetiapine Fumarate Sales Share by Type (2013-2018)
  • Figure Global Quetiapine Fumarate Sales Market Share by Type (2013-2018)
  • Figure Global Quetiapine Fumarate Sales Market Share by Type in 2017
  • Table Global Quetiapine Fumarate Revenue by Type (2013-2018) (Million US$)
  • Table Global Quetiapine Fumarate Revenue Share by Type (2013-2018)
  • Figure Global Quetiapine Fumarate Revenue Market Share by Type (2013-2018)
  • Figure Global Quetiapine Fumarate Revenue Market Share by Type in 2017
  • Table Quetiapine Fumarate Price by Type 2013-2018 (USD/Kg)
  • Table Global Quetiapine Fumarate Sales by Application (2013-2018) (MT)
  • Table Global Quetiapine Fumarate Sales Share by Application (2013-2018)
  • Figure Global Sales Quetiapine Fumarate Market Share by Application (2013-2018)
  • Figure Global Sales Quetiapine Fumarate Market Share by Application in 2017
  • Figure North America Quetiapine Fumarate Sales Growth Rate 2013-2018 (MT)
  • Figure North America Quetiapine Fumarate Revenue Growth Rate 2013-2018 (Million US$)
  • Table North America Quetiapine Fumarate Sales by Company (2013-2018) (MT)
  • Table North America Quetiapine Fumarate Sales Market Share by Company (2013-2018)
  • Figure North America Quetiapine Fumarate Sales Market Share by Company in 2018
  • Table North America Quetiapine Fumarate Sales by Type (2013-2018) (MT)
  • Table North America Quetiapine Fumarate Sales Market Share by Type (2013-2018)
  • Figure North America Quetiapine Fumarate Market Share by Type in 2018
  • Table North America Quetiapine Fumarate Sales by Application (2013-2018) (MT)
  • Table North America Quetiapine Fumarate Sales Market Share by Application (2013-2018)
  • Figure North America Quetiapine Fumarate Market Share by Application in 2018
  • Table North America Quetiapine Fumarate Sales by Countries (2013-2018) (MT)
  • Table North America Quetiapine Fumarate Sales Market Share by Countries (2013-2018)
  • Figure 2017 North America Quetiapine Fumarate Sales Market Share by Countries
  • Table North America Quetiapine Fumarate Revenue by Countries (2013-2018) (Million US$)
  • Table North America Quetiapine Fumarate Revenue Market Share by Countries (2013-2018)
  • Figure 2017 North America Quetiapine Fumarate Revenue Market Share by Countries
  • Figure United States Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Canada Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Mexico Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Europe Quetiapine Fumarate Sales Growth Rate 2013-2018 (MT)
  • Figure Europe Quetiapine Fumarate Revenue Growth Rate 2013-2018 (Million US$)
  • Table Europe Quetiapine Fumarate Sales by Company (2013-2018) (MT)
  • Table Europe Quetiapine Fumarate Sales Market Share by Company (2013-2018)
  • Figure Europe Quetiapine Fumarate Sales Market Share by Company in 2018
  • Table Europe Quetiapine Fumarate Sales by Type (2013-2018) (MT)
  • Table Europe Quetiapine Fumarate Sales Market Share by Type (2013-2018)
  • Figure 2017 Europe Quetiapine Fumarate Market Share by Type
  • Table Europe Quetiapine Fumarate Sales by Application (2013-2018) (MT)
  • Table Europe Quetiapine Fumarate Sales Market Share by Application (2013-2018)
  • Figure 2017 Europe Quetiapine Fumarate Market Share by Application
  • Table Europe Quetiapine Fumarate Sales by Countries (2013-2018) (MT)
  • Table Europe Quetiapine Fumarate Sales Market Share by Countries (2013-2018)
  • Figure 2017 Europe Quetiapine Fumarate Sales Market Share by Countries
  • Table Europe Quetiapine Fumarate Revenue by Countries (2013-2018) (Million US$)
  • Table Europe Quetiapine Fumarate Revenue Market Share by Countries (2013-2018)
  • Figure Europe Quetiapine Fumarate Revenue Market Share by Countries in 2018
  • Figure Germany Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure France Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure UK Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Italy Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Russia Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Asia Pacific Quetiapine Fumarate Sales Growth Rate 2013-2018 (MT)
  • Figure Asia Pacific Quetiapine Fumarate Revenue Growth Rate 2013-2018 (Million US$)
  • Table Asia Pacific Quetiapine Fumarate Sales by Company (2013-2018) (MT)
  • Table Asia Pacific Quetiapine Fumarate Sales Market Share by Company (2013-2018)
  • Figure Asia Pacific Quetiapine Fumarate Sales Market Share by Company in 2018
  • Table Asia Pacific Quetiapine Fumarate Sales by Type (2013-2018) (MT)
  • Table Asia Pacific Quetiapine Fumarate Sales Market Share by Type (2013-2018)
  • Figure Asia Pacific Quetiapine Fumarate Market Share by Type in 2018
  • Table Asia Pacific Quetiapine Fumarate Sales by Application (2013-2018) (MT)
  • Table Asia Pacific Quetiapine Fumarate Sales Market Share by Application (2013-2018)
  • Figure Asia Pacific Quetiapine Fumarate Market Share by Application in 2018
  • Table Asia Pacific Quetiapine Fumarate Sales by Countries (2013-2018) (MT)
  • Table Asia Pacific Quetiapine Fumarate Sales Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Quetiapine Fumarate Sales Market Share by Countries
  • Table Asia Pacific Quetiapine Fumarate Revenue by Countries (2013-2018) (Million US$)
  • Table Asia Pacific Quetiapine Fumarate Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Quetiapine Fumarate Revenue Market Share by Countries
  • Figure China Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure China Quetiapine Fumarate Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Japan Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Japan Quetiapine Fumarate Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Korea Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Korea Quetiapine Fumarate Revenue Growth Rate (2013-2018) (Million US$)
  • Figure India Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure India Quetiapine Fumarate Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Australia Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Australia Quetiapine Fumarate Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Indonesia Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Indonesia Quetiapine Fumarate Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Malaysia Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Malaysia Quetiapine Fumarate Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Philippines Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Philippines Quetiapine Fumarate Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Thailand Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Thailand Quetiapine Fumarate Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Vietnam Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Vietnam Quetiapine Fumarate Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Central & South America Quetiapine Fumarate Sales Growth Rate 2013-2018 (MT)
  • Figure Central & South America Quetiapine Fumarate Revenue Growth Rate 2013-2018 (Million US$)
  • Table Central & South America Quetiapine Fumarate Sales by Company (2013-2018) (MT)
  • Table Central & South America Quetiapine Fumarate Sales Market Share by Company (2013-2018)
  • Figure Central & South America Quetiapine Fumarate Sales Market Share by Company in 2018
  • Table Central & South America Quetiapine Fumarate Sales by Type (2013-2018) (MT)
  • Table Central & South America Quetiapine Fumarate Sales Market Share by Type (2013-2018)
  • Figure Central & South America Quetiapine Fumarate Market Share by Type in 2018
  • Table Central & South America Quetiapine Fumarate Sales by Application (2013-2018) (MT)
  • Table Central & South America Quetiapine Fumarate Sales Market Share by Application (2013-2018)
  • Figure Central & South America Quetiapine Fumarate Market Share by Application in 2018
  • Table Central & South America Quetiapine Fumarate Sales by Countries (2013-2018) (MT)
  • Table Central & South America Quetiapine Fumarate Sales Market Share by Countries (2013-2018)
  • Figure Central & South America Quetiapine Fumarate Sales Market Share by Countries in 2018
  • Table Central & South America Quetiapine Fumarate Revenue by Countries (2013-2018) (Million US$)
  • Table Central & South America Quetiapine Fumarate Revenue Market Share by Countries (2013-2018)
  • Figure Central & South America Quetiapine Fumarate Revenue Market Share by Countries in 2018
  • Figure Brazil Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Brazil Quetiapine Fumarate Revenue Growth Rate (2013-2018) (MT)
  • Figure Middle East and Africa Quetiapine Fumarate Sales Growth Rate 2013-2018 (MT)
  • Figure Middle East and Africa Quetiapine Fumarate Revenue Growth Rate 2013-2018 (Million US$)
  • Table Middle East and Africa Quetiapine Fumarate Sales by Type (2013-2018) (MT)
  • Table Middle East and Africa Quetiapine Fumarate Sales Market Share by Type (2013-2018)
  • Figure 2017 Middle East and Africa Quetiapine Fumarate Market Share by Type
  • Table Middle East and Africa Quetiapine Fumarate Sales by Application (2013-2018) (MT)
  • Table Middle East and Africa Quetiapine Fumarate Sales Market Share by Application (2013-2018)
  • Figure 2017 Middle East and Africa Quetiapine Fumarate Market Share by Application
  • Table Middle East and Africa Quetiapine Fumarate Sales by Countries (2013-2018) (MT)
  • Table Middle East and Africa Quetiapine Fumarate Sales Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Quetiapine Fumarate Sales Market Share by Countries
  • Table Middle East and Africa Quetiapine Fumarate Revenue by Countries (2013-2018) (Million US$)
  • Table Middle East and Africa Quetiapine Fumarate Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Quetiapine Fumarate Revenue Market Share by Countries
  • Figure GCC Countries Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure GCC Countries Quetiapine Fumarate Revenue Growth Rate (2013-2018) (MT)
  • Figure Egypt Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure Egypt Quetiapine Fumarate Revenue Growth Rate (2013-2018) (MT)
  • Figure South Africa Quetiapine Fumarate Sales Growth Rate (2013-2018) (MT)
  • Figure South Africa Quetiapine Fumarate Revenue Growth Rate (2013-2018) (MT)
  • Table AstraZeneca Company Details
  • Table AstraZeneca Description and Business Overview
  • Table AstraZeneca Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2013-2018)
  • Table AstraZeneca Quetiapine Fumarate Sales Growth Rate (2013-2018)
  • Table AstraZeneca Quetiapine Fumarate Sales Market Share in Global Market
  • Table AstraZeneca Recent Development
  • Table Intas Company Details
  • Table Intas Description and Business Overview
  • Table Intas Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2013-2018)
  • Table Intas Quetiapine Fumarate Sales Growth Rate (2013-2018)
  • Table Intas Quetiapine Fumarate Sales Market Share in Global Market
  • Table Intas Recent Development
  • Table TAPI Company Details
  • Table TAPI Description and Business Overview
  • Table TAPI Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2013-2018)
  • Table TAPI Quetiapine Fumarate Sales Growth Rate (2013-2018)
  • Table TAPI Quetiapine Fumarate Sales Market Share in Global Market
  • Table TAPI Recent Development
  • Table Accord Company Details
  • Table Accord Description and Business Overview
  • Table Accord Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2013-2018)
  • Table Accord Quetiapine Fumarate Sales Growth Rate (2013-2018)
  • Table Accord Quetiapine Fumarate Sales Market Share in Global Market
  • Table Accord Recent Development
  • Table Hexal Company Details
  • Table Hexal Description and Business Overview
  • Table Hexal Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2013-2018)
  • Table Hexal Quetiapine Fumarate Sales Growth Rate (2013-2018)
  • Table Hexal Quetiapine Fumarate Sales Market Share in Global Market
  • Table Hexal Recent Development
  • Table Dr.Reddy's Company Details
  • Table Dr.Reddy's Description and Business Overview
  • Table Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2013-2018)
  • Table Dr.Reddy's Quetiapine Fumarate Sales Growth Rate (2013-2018)
  • Table Dr.Reddy's Quetiapine Fumarate Sales Market Share in Global Market
  • Table Dr.Reddy's Recent Development
  • Table Lupin Company Details
  • Table Lupin Description and Business Overview
  • Table Lupin Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2013-2018)
  • Table Lupin Quetiapine Fumarate Sales Growth Rate (2013-2018)
  • Table Lupin Quetiapine Fumarate Sales Market Share in Global Market
  • Table Lupin Recent Development
  • Table Sun Pharmaceutical Company Details
  • Table Sun Pharmaceutical Description and Business Overview
  • Table Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2013-2018)
  • Table Sun Pharmaceutical Quetiapine Fumarate Sales Growth Rate (2013-2018)
  • Table Sun Pharmaceutical Quetiapine Fumarate Sales Market Share in Global Market
  • Table Sun Pharmaceutical Recent Development
  • Table Hunan Dongting Pharm Company Details
  • Table Hunan Dongting Pharm Description and Business Overview
  • Table Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2013-2018)
  • Table Hunan Dongting Pharm Quetiapine Fumarate Sales Growth Rate (2013-2018)
  • Table Hunan Dongting Pharm Quetiapine Fumarate Sales Market Share in Global Market
  • Table Hunan Dongting Pharm Recent Development
  • Table SuZhou NO.4 Phamaceutical Factory Company Details
  • Table SuZhou NO.4 Phamaceutical Factory Description and Business Overview
  • Table SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2013-2018)
  • Table SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales Growth Rate (2013-2018)
  • Table SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales Market Share in Global Market
  • Table SuZhou NO.4 Phamaceutical Factory Recent Development
  • Figure Quetiapine Fumarate Value Chain
  • Table Quetiapine Fumarate Distributors List
  • Table Quetiapine Fumarate Customers List
  • Table Global Quetiapine Fumarate Sales Forecast 2018-2025 (MT) & (Million US$)
  • Figure Global Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure Global Quetiapine Fumarate Revenue Forecast 2018-2025 (Million US$)
  • Table Global Quetiapine Fumarate Sales Forecast by Type 2018-2025 (MT)
  • Figure Global Quetiapine Fumarate Sales Forecast by Type 2018-2025 (MT)
  • Figure Global Quetiapine Fumarate Sales Market Share Forecast by Type 2018-2025
  • Table Global Quetiapine Fumarate Sales Forecast by Application 2018-2025 (MT)
  • Figure Global Quetiapine Fumarate Sales Forecast by Application 2018-2025 (MT)
  • Figure Global Quetiapine Fumarate Sales Market Share Forecast by Application 2018-2025
  • Table Global Quetiapine Fumarate Sales Forecast by Regions 2018-2025 (MT)
  • Figure Global Quetiapine Fumarate Sales Forecast by Regions 2018-2025 (MT)
  • Figure Global Quetiapine Fumarate Sales Market Share Forecast by Regions 2018-2025
  • Table Global Quetiapine Fumarate Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Quetiapine Fumarate Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Quetiapine Fumarate Revenue Market Share Forecast by Regions 2018-2025
  • Table North America Quetiapine Fumarate Sales Forecast by Countries 2018-2025 (MT)
  • Table North America Quetiapine Fumarate Sales Market Share Forecast by Countries 2018-2025
  • Table North America Quetiapine Fumarate Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table North America Quetiapine Fumarate Revenue Market Share Forecast by Countries 2018-2025
  • Figure United States Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure Canada Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure MexicoQuetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Table Europe Quetiapine Fumarate Sales Forecast by Countries 2018-2025 (MT)
  • Table Europe Quetiapine Fumarate Sales Market Share Forecast by Countries 2018-2025
  • Table Europe Quetiapine Fumarate Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Europe Quetiapine Fumarate Revenue Market Share Forecast by Countries 2018-2025
  • Figure Germany Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure France Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure UK Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure Italy Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure Russia Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Table Asia Pacific Quetiapine Fumarate Sales Forecast by Countries 2018-2025 (MT)
  • Table Asia Pacific Quetiapine Fumarate Sales Market Share Forecast by Countries 2018-2025
  • Table Asia Pacific Quetiapine Fumarate Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Asia Pacific Quetiapine Fumarate Revenue Market Share Forecast by Countries 2018-2025
  • Figure China Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure Japan Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure Korea Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure India Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure Australia Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure Indonesia Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure Thailand Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure Malaysia Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure Philippines Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Figure Vietnam Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Table Central & South America Quetiapine Fumarate Sales Forecast by Countries 2018-2025 (MT)
  • Table Central & South America Quetiapine Fumarate Sales Market Share Forecast by Countries 2018-2025
  • Table Central & South America Quetiapine Fumarate Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Central & South America Quetiapine Fumarate Revenue Market Share Forecast by Countries 2018-2025
  • Figure Brazil Quetiapine Fumarate Sales Forecast 2018-2025 (MT)
  • Table Middle East and Africa Quetiapine Fumarate Sales Forecast by Regions 2018-2025 (MT)
  • Table Middle East and Africa Quetiapine Fumarate Sales Market Share Forecast by Regions 2018-2025
  • Table Middle East and Africa Quetiapine Fumarate Revenue Forecast by Regions 2018-2025 (Million US$)
  • Table Middle East and Africa Quetiapine Fumarate Revenue Market Share Forecast by Regions 2018-2025
  • Figure GCC Countries Quetiapine Fumarate Sales Growth Rate (2016-2025) (MT)
  • Figure Egypt Quetiapine Fumarate Sales Growth Rate (2016-2025) (MT)
  • Figure South Africa Quetiapine Fumarate Sales Growth Rate (2016-2025) (MT)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
Back to Top